A person's risk of developing cancer is affected by genetic variations in regions of DNA that don't code for proteins, previously dismissed as 'junk DNA', according to new research published in the British Journal of Cancer ...
Dec 6, 2019
0
161
Temporarily disabling a single protein inside our cells might be able to protect us from the common cold and other viral diseases, according to a study led by researchers at Stanford University and University of California-San ...
Sep 16, 2019
1
386
Scientists using a powerful new technology that sequences RNA in 20,000 individual cell nuclei have uncovered new insights into biological events in heart disease. In animal studies, the researchers identified a broad variety ...
Oct 5, 2018
0
73
A single chip is wreaking havoc in school districts across the country, sending children home sick and sometimes even to a hospital. The "One Chip Challenge," which has over 850 million views on TikTok, is making a bold return ...
Oct 5, 2022
0
35
The APOE4 gene is the most powerful genetic factor driving a person's risk for developing late-onset Alzheimer's disease.
Jun 1, 2022
0
105
The most common cause of spontaneous abortions is chromosome defects, but they can be difficult to detect. Researchers from the University of Copenhagen have developed a new method that can make us wiser about how chromosome ...
May 25, 2022
0
51
Although mask mandates are lifting in some states, many people will continue to wear masks to protect themselves and others from the more transmissible omicron variant.
Feb 24, 2022
0
5
A cost-effective strategy for health care systems to offset N95 mask shortages due to the Coronavirus Disease 2019 (COVID-19) pandemic is to switch to reusable elastomeric respirator masks, according to new study results. ...
Jun 12, 2020
0
6
In most cases, your genes have less than five percent to do with your risk of developing a particular disease, according to new research by University of Alberta scientists.
Dec 19, 2019
0
403
(HealthDay)—MiSight, the first contact lens indicated to slow the progression of myopia in children ages 8 to 12 years, has been approved by the U.S. Food and Drug Administration, the agency announced Friday.
Nov 18, 2019
0
7
